Science Explorer Back to mapMap
Discussion
Researcher · Sağlık Bilimleri Üniversitesi · Türkiye

Mehmet Bakırtaş

Mehmet Bakırtaş publishes mostly in Hematology, Oncology and Pathology and Forensic Medicine, on topics such as Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation and Multiple Myeloma Research and Treatments.

ORCID 0000-0003-3216-482X OpenAlex
World rank
#7,666,584
of 7,710,434 ranked researchers
Rank in Türkiye
#116,122
of 117,622
Works
77
Citations
110
Citations per work
1.4
h-index
6
i10-index 4Top 84% in Hematology
Mehmet Bakırtaş

What does Mehmet Bakırtaş research?

Mehmet Bakırtaş's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 42 works · 55.0% of their workMedicine: 42 works · 55.0% of their workHematology: 16 works · 21.4% of their workOncology: 9 works · 12.3% of their workPathology and Forensic Medicine: 7 works · 9.1% of their workGenetics: 6 works · 7.7% of their workEpidemiology: 3 works · 4.5% of their workEverything else: 29 works · 38.2% of their workLife Sciences: 5 works · 6.8% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 6.8% of their workMolecular Biology: 5 works · 6.8% of their workTHEIR WORKMehmet Bakırtaş77works
Life Sciences7%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4255.0%
  2. Everything else2938.2%
    1. Biochemistry, Genetics and Molecular Biology56.8%
  1. 1Hematology21% of their works
  2. 2Oncology12% of their works
  3. 3Pathology and Forensic Medicine9% of their works
  4. 4Genetics8% of their works
  5. 5Molecular Biology7% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Mehmet Bakırtaş's research?

The keywords of their largest research topics: Rituximab, Hematopoietic Stem Cells, Classification, Lymphoma, Prognostic Factors, Bone Marrow Niche, Chemotherapy and Graft-versus-Host Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Rituximab292 topics
  2. Hematopoietic Stem Cells222 topics
  3. Classification191 topic
  4. Lymphoma191 topic
  5. Prognostic Factors172 topics
  6. Bone Marrow Niche151 topic
  7. Chemotherapy152 topics
  8. Graft-versus-Host Disease151 topic
  9. Diagnosis Criteria141 topic
  10. International Myeloma Working Group141 topic
  11. Chronic Lymphocytic Leukemia101 topic
  12. Genomic Aberrations101 topic
  13. Antimicrobial Agents81 topic
  14. Febrile Neutropenia81 topic
  15. AML71 topic
  16. Acute Myeloid Leukemia71 topic
  17. Primary CNS Lymphoma71 topic
  18. Prognostic Scoring System71 topic
  19. HDAC Inhibitors61 topic
  20. Histone Deacetylases61 topic

Where does Mehmet Bakırtaş work?

Mehmet Bakırtaş's main affiliation in the publication record is Sağlık Bilimleri Üniversitesi, Türkiye.

How many publications and citations does Mehmet Bakırtaş have?

OpenAlex counts 77 works and 110 citations for Mehmet Bakırtaş, an h-index of 6, ranking #7,666,584 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mehmet Bakırtaş. Posts are plain text and can be reported.